-
PDF
- Split View
-
Views
-
Cite
Cite
Giuseppe Quero, Claudio Fiorillo, Chiara Lucinato, Flavia Taglioni, Vito Laterza, Edoardo Panza, Giuseppe Massimiani, Teresa Mezza, Roberta Menghi, Ludovica Di Cesare, Beatrice Biffoni, Davide De Sio, Fausto Rosa, Vincenzo Tondolo, Sergio Alfieri, Post-pancreatectomy acute pancreatitis and pancreatic fistula after pancreatoduodenectomy: two distinct but potentially correlated clinical entities, BJS Open, Volume 8, Issue 5, October 2024, zrae107, https://doi.org/10.1093/bjsopen/zrae107
- Share Icon Share
Postoperative pancreatic fistula (POPF) is the most concerning post-pancreatoduodenectomy (PD) complication, potentially leading to additional adverse events1. Although several surgical and anatomical factors have been recognized as predisposing to POPF1, the correlation between postpancreatectomy acute pancreatitis (PPAP) and POPF is still under investigation. Some authors report PPAP as an indirect sign of POPF, suggesting that local inflammation may cause pancreatic oedema and impair the anastomotic healing, contributing to POPF development2. Others identify PPAP as an independent complication not necessarily linked to POPF3. These discrepancies are partly due to the long-standing absence of a universal definition of PPAP. The International Study Group of Pancreatic Surgery (ISGPS) provided a consensus definition of PPAP based on postoperative hyperamylasaemia (POH) and radiological alterations4. This definition shows a more detrimental post-PD course in the case of PPAP onset5, but the correlation between PPAP and POPF development is still lacking. This study aimed to analyse the impact of PPAP on the clinical course after PD, focusing on the potential correlation between PPAP and POPF occurrence, and further evaluating the clinical course based on the independent or combined occurrence of these complications.
All clinicodemographic and perioperative data of patients who underwent PD from January 2006 to November 2023 at the Pancreatic Surgery Unit of the Fondazione Policlinico Universitario Agostino Gemelli IRCCS (Istituti di ricovero e cura a carattere scientifico) of Rome were retrospectively retrieved. Postoperative complications were graded according to the Clavien–Dindo classification (Supplementary reference S1). POPF, delayed gastric emptying (DGE), postpancreatectomy haemorrhage (PPH) and PPAP were classified according to the ISGPS criteria4 (Supplementary references S2–S4). POPF monitoring was based on drainage amylase values, while, per protocol, serum amylase values for PPAP diagnosis were evaluated on postoperative day (POD) 1 and 3, more rarely on POD 2. Statistical analysis is reported in the Supplementary methods.
During the study interval, 620 patients underwent PD. POH was documented in 74 patients (11.9%) and PPAP in 70 patients (11.3%; 60 grade B and 10 grade C). PPAP patients had higher rates of Clavien–Dindo equal to or greater than grade IIIb complications, including DGE, abscesses, biliary fistula, sepsis, pneumonia and cardiac complications. PPAP was also associated with a more severe POPF, with 35 PPAP patients (50%) developing a clinically relevant (CR)-POPF compared with 98 (17.8%) in the no-PPAP group (Table S1). Predictive factors for PPAP included a soft pancreatic texture and a Wirsung diameter equal to or less than 3 mm. Both were confirmed as independent predictors of PPAP (Table S2).
Of 133 (21.4%) patients with CR-POPF (105 grade B and 28 grade C), 35 (26.3%) had PPAP while 26 (19.5%) presented POH. Lesions other than pancreatic adenocarcinoma, a soft pancreatic texture, a Wirsung diameter equal to or less than 3 mm and POH were independent predictive factors for CR-POPF (Table S3).
Table 1 shows the post-PD clinical course according to the development of PPAP and CR-POPF alone or in association. Patients who developed both PPAP and CR-POPF presented a significantly higher rate of Clavien–Dindo equal to or greater than grade IIIb complications, PPH and reoperation on as compared with PPAP alone (10 patients versus 6, P = 0.042; 5 patients versus 0, P = 0.020; 12 patients versus 5, P = 0.032 respectively). Patients who presented CR-POPF alone as compared with PPAP alone had a higher frequency of Clavien–Dindo equal to or greater than grade IIIb complications, PPH and reoperation on (35 patients versus 6, P = 0.041; 10 patients versus 0, P = 0.050; 38 patients versus 5, P = 0.008 respectively). No difference was noted in terms of postoperative outcomes between CR-POPF alone and CR-POPF + PPAP.
Variables . | PPAP+/CR-POPF− (n = 35) . | PPAP−/CR-POPF+ (n = 98) . | PPAP+/CR-POPF+ (n = 35) . | P* . | P** . | P*** . |
---|---|---|---|---|---|---|
Clavien–Dindo ≥IIIb | 6 (17.1) | 35 (35.7) | 10 (28.6) | 0.04 | 0.44 | 0.04 |
PPH | 0 | 10 (10.2) | 5 (14.3) | 0.05 | 0.51 | 0.02 |
DGE | 17 (48.6) | 36 (36.7) | 14 (40) | 0.22 | 0.73 | 0.47 |
Abscess | 26 (74.3) | 56 (57.1) | 23 (65.7) | 0.07 | 0.37 | 0.43 |
Biliary fistula | 4 (11.4) | 6 (6.1) | 3 (8.6) | 0.3 | 0.62 | 0.69 |
Sepsis | 5 (14.3) | 9 (9.2) | 7 (20) | 0.4 | 0.09 | 0.52 |
Pneumonia | 3 (8.6) | 23 (23.5) | 7 (20) | 0.06 | 0.67 | 0.17 |
Cardiological complication | 2 (5.7) | 7 (7.1) | 1 (2.9) | 0.77 | 0.36 | 0.55 |
Reoperation on | 5 (14.3) | 38 (38.8) | 12 (34.3) | 0.008 | 0.63 | 0.03 |
LOS (days), median (i.q.r.) | 18 (11–20) | 16 (12–21) | 19 (12–27) | 0.75 | 0.21 | 0.14 |
30-day mortality rate | 0 | 3 (3.1) | 2 (5.7) | 0.29 | 0.48 | 0.15 |
Variables . | PPAP+/CR-POPF− (n = 35) . | PPAP−/CR-POPF+ (n = 98) . | PPAP+/CR-POPF+ (n = 35) . | P* . | P** . | P*** . |
---|---|---|---|---|---|---|
Clavien–Dindo ≥IIIb | 6 (17.1) | 35 (35.7) | 10 (28.6) | 0.04 | 0.44 | 0.04 |
PPH | 0 | 10 (10.2) | 5 (14.3) | 0.05 | 0.51 | 0.02 |
DGE | 17 (48.6) | 36 (36.7) | 14 (40) | 0.22 | 0.73 | 0.47 |
Abscess | 26 (74.3) | 56 (57.1) | 23 (65.7) | 0.07 | 0.37 | 0.43 |
Biliary fistula | 4 (11.4) | 6 (6.1) | 3 (8.6) | 0.3 | 0.62 | 0.69 |
Sepsis | 5 (14.3) | 9 (9.2) | 7 (20) | 0.4 | 0.09 | 0.52 |
Pneumonia | 3 (8.6) | 23 (23.5) | 7 (20) | 0.06 | 0.67 | 0.17 |
Cardiological complication | 2 (5.7) | 7 (7.1) | 1 (2.9) | 0.77 | 0.36 | 0.55 |
Reoperation on | 5 (14.3) | 38 (38.8) | 12 (34.3) | 0.008 | 0.63 | 0.03 |
LOS (days), median (i.q.r.) | 18 (11–20) | 16 (12–21) | 19 (12–27) | 0.75 | 0.21 | 0.14 |
30-day mortality rate | 0 | 3 (3.1) | 2 (5.7) | 0.29 | 0.48 | 0.15 |
Values are n (%) unless otherwise stated. *P value for PPAP+/CR-POPF− and PPAP-/CR-POPF+; **P value for PPAP−/CR-POPF+ and PPAP+/CR-POPF+; ***P value for PPAP+/CR-POPF− and PPAP+/CR-POPF+. Values in bold are statistically significant. PPAP, postpancreatectomy acute pancreatitis; CR-POPF, clinically relevant postoperative pancreatic fistula; PPH, postpancreatectomy haemorrhage; DGE, delayed gastric emptying; LOS, length of hospital stay; i.q.r., interquartile range.
Variables . | PPAP+/CR-POPF− (n = 35) . | PPAP−/CR-POPF+ (n = 98) . | PPAP+/CR-POPF+ (n = 35) . | P* . | P** . | P*** . |
---|---|---|---|---|---|---|
Clavien–Dindo ≥IIIb | 6 (17.1) | 35 (35.7) | 10 (28.6) | 0.04 | 0.44 | 0.04 |
PPH | 0 | 10 (10.2) | 5 (14.3) | 0.05 | 0.51 | 0.02 |
DGE | 17 (48.6) | 36 (36.7) | 14 (40) | 0.22 | 0.73 | 0.47 |
Abscess | 26 (74.3) | 56 (57.1) | 23 (65.7) | 0.07 | 0.37 | 0.43 |
Biliary fistula | 4 (11.4) | 6 (6.1) | 3 (8.6) | 0.3 | 0.62 | 0.69 |
Sepsis | 5 (14.3) | 9 (9.2) | 7 (20) | 0.4 | 0.09 | 0.52 |
Pneumonia | 3 (8.6) | 23 (23.5) | 7 (20) | 0.06 | 0.67 | 0.17 |
Cardiological complication | 2 (5.7) | 7 (7.1) | 1 (2.9) | 0.77 | 0.36 | 0.55 |
Reoperation on | 5 (14.3) | 38 (38.8) | 12 (34.3) | 0.008 | 0.63 | 0.03 |
LOS (days), median (i.q.r.) | 18 (11–20) | 16 (12–21) | 19 (12–27) | 0.75 | 0.21 | 0.14 |
30-day mortality rate | 0 | 3 (3.1) | 2 (5.7) | 0.29 | 0.48 | 0.15 |
Variables . | PPAP+/CR-POPF− (n = 35) . | PPAP−/CR-POPF+ (n = 98) . | PPAP+/CR-POPF+ (n = 35) . | P* . | P** . | P*** . |
---|---|---|---|---|---|---|
Clavien–Dindo ≥IIIb | 6 (17.1) | 35 (35.7) | 10 (28.6) | 0.04 | 0.44 | 0.04 |
PPH | 0 | 10 (10.2) | 5 (14.3) | 0.05 | 0.51 | 0.02 |
DGE | 17 (48.6) | 36 (36.7) | 14 (40) | 0.22 | 0.73 | 0.47 |
Abscess | 26 (74.3) | 56 (57.1) | 23 (65.7) | 0.07 | 0.37 | 0.43 |
Biliary fistula | 4 (11.4) | 6 (6.1) | 3 (8.6) | 0.3 | 0.62 | 0.69 |
Sepsis | 5 (14.3) | 9 (9.2) | 7 (20) | 0.4 | 0.09 | 0.52 |
Pneumonia | 3 (8.6) | 23 (23.5) | 7 (20) | 0.06 | 0.67 | 0.17 |
Cardiological complication | 2 (5.7) | 7 (7.1) | 1 (2.9) | 0.77 | 0.36 | 0.55 |
Reoperation on | 5 (14.3) | 38 (38.8) | 12 (34.3) | 0.008 | 0.63 | 0.03 |
LOS (days), median (i.q.r.) | 18 (11–20) | 16 (12–21) | 19 (12–27) | 0.75 | 0.21 | 0.14 |
30-day mortality rate | 0 | 3 (3.1) | 2 (5.7) | 0.29 | 0.48 | 0.15 |
Values are n (%) unless otherwise stated. *P value for PPAP+/CR-POPF− and PPAP-/CR-POPF+; **P value for PPAP−/CR-POPF+ and PPAP+/CR-POPF+; ***P value for PPAP+/CR-POPF− and PPAP+/CR-POPF+. Values in bold are statistically significant. PPAP, postpancreatectomy acute pancreatitis; CR-POPF, clinically relevant postoperative pancreatic fistula; PPH, postpancreatectomy haemorrhage; DGE, delayed gastric emptying; LOS, length of hospital stay; i.q.r., interquartile range.
According to the present findings, PPAP and POPF may be considered two distinct clinical entities. A certain correlation between them is undeniable, especially in relation to the recognition of similar independent risk factors for their occurrence and the key role of POH in predisposing to POPF. Their concomitant occurrence inevitably leads to a more severe post-PD course.
Funding
The authors have no funding to declare.
Disclosure
The authors declare no conflict of interest.
Supplementary material
Supplementary material is available at BJS Open online.
Data availability
Data that support the findings of this study are available upon reasonable request from the corresponding author.
Author contributions
Giuseppe Quero (Conceptualization, Writing—original draft), Claudio Fiorillo (Conceptualization, Data curation, Formal analysis), Chiara Lucinato (Data curation, Formal analysis, Investigation), Flavia Taglioni (Investigation, Methodology), Vito Laterza (Investigation, Methodology, Writing—original draft), Edoardo Panza (Data curation, Investigation), Giuseppe Massimiani (Data curation, Writing—original draft), Teresa Mezza (Conceptualization, Supervision), Roberta Menghi (Formal analysis, Investigation, Methodology), Ludovica Di Cesare (Data curation, Project administration), Beatrice Biffoni (Data curation, Supervision, Writing—original draft), Davide De Sio (Data curation, Formal analysis, Investigation), Fausto Rosa (Validation, Writing—review & editing), Vincenzo Tondolo (Validation, Visualization, Writing—review & editing) and Sergio Alfieri (Validation, Visualization, Writing—review & editing)